NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) ("NurExone" or the "Company"), a biopharmaceutical company developing exosome-based ...
The treatments for men and women may be slightly different as their physiologies are different. Coolen, who is researching ...
NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (" NurExone " or the " Company "), a biopharmaceutical company developing exosome-based regenerative therapies, is pleased to announce ...
A team of researchers led by Rice University's Jacob Robinson and the University of Texas Medical Branch's Peter Kan has ...
GlobalData on MSN1d
Nevro secures CE mark for AI-based spinal cord stimulation systemUS-based device company Nevro has secured market authorisation from the European Union (EU) for its HFX iQ spinal cord ...
Researchers at Kennedy Krieger Institute report that Transcutaneous Spinal Cord Stimulation (TSS) combined with movement ...
The study involved four children with spinal cord injuries caused by AFM ... at Kennedy Krieger offers hope to families who often have limited options. "This treatment is giving families a ...
Researchers at Kennedy Krieger Institute's International Center for Spinal Cord Injury (ICSCI) have made a remarkable advancement in treating children with Acute Flaccid Myelitis (AFM), a rare but ...
Researchers at Kennedy Krieger Institute's International Center for Spinal Cord Injury (ICSCI) have made a remarkable ...
Natalie Barnhard Catstrogiovanni founded her center for those recovering from traumatic injury. 20-years after her injury, she shares her story and big plans.
Here's what a herniated disc is, what causes it and what sort of treatment options are available and recommended if you experience one.
NASS’s 2024 Research Funding Program announced grants and traveling fellowships winners totaling $159,059 this year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback